IGEM:IMPERIAL/2007/Projects/In-Veso/Design: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 43: Line 43:


[[Image:Icgems_cbd-design.jpg]]
[[Image:Icgems_cbd-design.jpg]]
pT7 not found in the registry.


== Preparation of E.coli Extracts ==
== Preparation of E.coli Extracts ==

Revision as of 03:07, 30 July 2007

In-Veso Gene Expression: Design



Summary

Characterisation Stages

Characerisation of the vesicle chassis will proceed in two stages.
Stage 1: In-vitro control experiments

  • Establishes a platform for comparison of techniques
  • Tests whether constructs and components are working

Stage 2: In-veso characterisation

For both stages, there are two preparatory steps that need to be carried out - preparing the DNA constructs to be tested, and preparing the chassis (solution or vesicles). Between the two stages, the only step that varies is the preparation of the chassis. Further, the only difference between the in-vitro and in-veso preparations is the additional step of creating vesicles. Both chassis will be using the same cell extracts. The DNA constructs and experiments will be the same for both stages.

Characterisation of the E.coli chassis will proceed in one stage, in parallel to the vesicle chassis characterisation. This will serve two purposes: first, it will provide a platform for comparison with the vesicle chassis; second, it will provide a contingency in case the vesicle chassis does not work.

DNA Constructs

pTet GFP found in registry:BBa_I13522
Untagged GFP behind a constitutive promoter


Circular plasmid in registry(GFP gene included): iGEM 2007 15H iGEM 2007 Parts Kit Plate 2 Plasmid: pSB1A2 Cell: V1002


pT7 not found in the registry.

Preparation of E.coli Extracts

Simple procedures for the construction of a robust and cost-effective cell-free protein synthesis system [1]

There are two choices for making cell extract from E.coli. One of them is S30, and the other is the S12 method, which is a more rapid and cost-effective preparation. The cell extracts can also be obtained from a manufacturer.

We have protocols for boths extracts, to be chosen depending on the E.coli strain that will be used:

A single batch of E.coli extract will be prepared for use in all experiments.

Formation of Vesicles

This step converts the in vitro expression system to the in veso expression system by encapsulating the E.coli cell extract in a phospholipid bilayer vesicle.

Formation of vesicles [2]


Experiments

The following chart cross-references the input variables to the dependent quantities. Each cell links to the protocol for that experiment. The number in each cell corresponds to the priority of that experiment.

Lifespan Rate of Protein
Synthesis
PoPS Effect Membrane Traffic
Temperature 1 3
Media 2 4
Parts
Piping

Testing In Vitro system


1. Do both S30 and S12 extract on the K12 strain at 25°C.
2. Add E.coli and T7 RNA polymerases separately to each cell extract.
3. Make a reporter gene construct for GFP using pLux and T7 promoters respectively.
4. Mix gene contructs with S30 cell extracts.
*E.coli RNAP + pLux
*T7 RNAP + T7 promoter
5. Repeat step 4 with S12 cell extracts.
6. Measure fluorescence intensity at hourly intervals for 5 hours.
7. Determine the optimal translational activity of S30 and S12.
8. Choose which ever is best for strain K12.
9. Carry out subsequent experiments with the appropriate cell extract.

Testing Temperature Dependence


1. Carry out steps 2 to 6 at 4°C, 10°C, 15°C, 20°C, 25°C, 30°C, and 37°C; at pH 7.
2. Measure fluorescence intensity at hourly intervals for 5 hours.

Testing pH Dependence


1. Carry out steps 2 to 6 at pH 2, 4, 6, 7, 8, 10, 12; at 25°C.
2. Measure fluorescence intensity at hourly intervals for 5 hours.

Testing Lifespan of the system

Testing In Veso System


1. Follow the protocol for vesicle preparation in the "Design" section.
2. Repeat steps 2 to 6 above using only the optimal cell extract solution.

Testing for membrane trafficking and pore formation


1. Insert fluorescent markers BSA-rhodamine and UTP-fluorescein into the cell extract before vesicle formation.
2. Follow protocol for vesicle formation.
3. Observe fluorescence patterns in the feeding solution and vesicles.

Testing Temperature Dependence


1. Carry out steps 2 to 6 at 4°C, 10°C, 15°C, 20°C, 25°C, 30°C, and 37°C; at pH 7.
2. Measure fluorescence intensity at hourly intervals for 5 hours.

Testing pH Dependence


1. Carry out steps 2 to 6 at pH 2, 4, 6, 7, 8, 10, 12; at 25°C.
2. Measure fluorescence intensity at hourly intervals for 5 hours.

Testing Lifespan of the system

Materials Required

Schedule of Experiments


Grow E.coli strains --- prepare DNA constructs
E.coli experiments --- prepare E.coli extract
--- in-vitro experiments --- prepare vesicles
--- in-veso experiments

Protocols

ATP regenerating system

For preparation of the cell extract, we would want to use a cell-free protein synthesis system that is capable of using pyruvate as an energy source to produce high yields of protein. The Cytomim system, synthesizes chloramphenicol acetyltransferase (CAT) for up to 6 h in a batch reaction to yield 700 g/mL of protein. It provides a stable energy supply for protein expression without phosphate accumulation, pH change, exogenous enzyme addition, or the need for expensive high-energy phosphate compounds.

References

  1. Kim TW, Keum JW, Oh IS, Choi CY, Park CG, and Kim DM. Simple procedures for the construction of a robust and cost-effective cell-free protein synthesis system. J Biotechnol. 2006 Dec 1;126(4):554-61. DOI:10.1016/j.jbiotec.2006.05.014 | PubMed ID:16797767 | HubMed [Kim]
  2. Noireaux V, Bar-Ziv R, Godefroy J, Salman H, and Libchaber A. Toward an artificial cell based on gene expression in vesicles. Phys Biol. 2005 Sep 15;2(3):P1-8. DOI:10.1088/1478-3975/2/3/P01 | PubMed ID:16224117 | HubMed [Noireux]
  3. Pellinen T, Huovinen T, and Karp M. A cell-free biosensor for the detection of transcriptional inducers using firefly luciferase as a reporter. Anal Biochem. 2004 Jul 1;330(1):52-7. DOI:10.1016/j.ab.2004.03.064 | PubMed ID:15183761 | HubMed [Pellinen]

All Medline abstracts: PubMed | HubMed